We use cookies to personalise content, analyse traffic and provide adverts via a third party. For more information on how we use cookies read our cookie policy in full.
You can change your cookie settings at any time, but parts of our site will not function correctly without them. Learn more about cookies.

• Buy Oxford Biomedica (OXB) by Stifel
• Hold International Distributions Services (IDS) by Deutsche Bank
• Buy W.A.G Payment Solutions (WPS) by UBS
• Neutral RS Group (RS1) by UBS
• Outperform Diageo (DGE) by Bernstein
• Buy Haleon (HLN) by HSBC
• Hold Flutter Entertainment (DI) (FLTR) by HSBC
• Buy Spire Healthcare Group (SPI) by Berenberg
• Outperform Spire Healthcare Group (SPI) by RBC Capital
• Outperform Ashtead Technology Holdings (AT.) by RBC Capital
• Underweight Antofagasta (ANTO) by JP Morgan
• Overweight Rio Tinto (RIO) by JP Morgan
• Neutral SSP Group (SSPG) by UBS
• Neutral Entain (ENT) by UBS
• Buy Harbour Energy (HBR) by Jefferies
• Buy Standard Chartered (STAN) by Jefferies
• Hold Savills (SVS) by Katie Prescott in The Times - Tempus
• Buy RIT Capital Partners (RCP) by Gavin Lumsden in The Telegraph - Questor
• Buy GSK (GSK) by Deutsche Bank
• Buy Rio Tinto (RIO) by Bank of America